All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Extremity Part | NCIT_C38630 | [Any component associated with the end of a pointed or elongated structure.] |
| Human Blood Product-Derived Intermediate Paste Production | NCIT_C112938 | [The production of concentrated proteins from human plasma during a protein purification process.] |
| Plasma Protein Cold Ethanol Fractionation | NCIT_C112939 | [A multistep purification process that isolates plasma proteins based upon the differential solubility of proteins in ethanol solutions.] |
| Cell Separation by Density Gradient Centrifugation | NCIT_C112934 | [A method of separating cells by either their differential rate of sedimentation in a centrifugal gradient or their differential buoyancy in a density gradient.] |
| Collection of Non-Human Source Plasma | NCIT_C112935 | [The collection of the fluid portion of non-human blood intended as a source material for further manufacture.] |
| Harvest of Product from Cell Media | NCIT_C112936 | [Collection of a material of interest from a cell culture supernatant.] |
| Harvest of Product from Whole Cell Lysate | NCIT_C112937 | [Collection of a material of interest from a cell lysate.] |
| Antigen Reagent Production | NCIT_C112930 | [A procedure to manufacture blood group antigens or cellular reagents for donor and recipient typing of blood or organs.] |
| Anti-Human Globulin Preparation | NCIT_C112931 | [A procedure to isolate one or more anti-globulin antibodies from either serum derived from animals immunized with human serum globulins or from fluids harvested from stable immunoglobulin-secreting cell lines.] |
| Blood Product Collection | NCIT_C112932 | [Any process that harvests blood or blood products for clinical or manufacturing purposes.] |
| Bone Marrow Collection | NCIT_C112933 | [Any process that harvests bone marrow for clinical or manufacturing purposes.] |
| Uterine Corpus Apoplectic Leiomyoma | NCIT_C40165 | [A morphologic variant of uterine corpus leiomyoma characterized by zones of hemorrhagic infarction surrounded by hypercellular areas. It usually develops in women of childbearing years, particularly those that are pregnant, post-partum, or taking oral contraceptives.] |
| Uterine Corpus Myxoid Leiomyoma | NCIT_C40166 | [A morphologic variant of uterine corpus leiomyoma characterized by extensive myxoid degeneration of the neoplasm connective tissue stroma.] |
| Myxoid Leiomyoma | NCIT_C67563 | [A leiomyoma characterized by the presence of abundant myxoid matrix.] |
| Uterine Corpus Bizarre Leiomyoma | NCIT_C40167 | [A morphologic variant of uterine corpus leiomyoma characterized by significant cytologic atypia. The atypical cells are large with pleomophic hyperchromatic nuclei.] |
| Bizarre Leiomyoma | NCIT_C4257 | [A morphologic variant of leiomyoma characterized by the presence of pleomorphic muscle cells with bizarre hyperchromatic nuclei and eosinophilic cytoplasm.] |
| Uterine Corpus Lipoleiomyoma | NCIT_C40168 | [A rare morphologic variant of uterine corpus leiomyoma characterized by the presence of scattered islands of mature adipocytes within the smooth muscle neoplasm.] |
| Uterine Corpus Diffuse Leiomyomatosis | NCIT_C40169 | |
| Uterine Corpus Diffuse Leiomyomatosis | NCIT_C40170 | [An unusual condition characterized by the presence of numerous small benign smooth muscle neoplasms located throughout the body of the uterus.] |
| Leiomyomatosis | NCIT_C3748 | [A condition characterized by the presence of numerous small benign smooth muscle neoplasms located throughout the body.] |